Pharmacology, Toxicology and Pharmaceutical Science
Alkyne
50%
Ampicillin
50%
Amyotrophic Lateral Sclerosis
100%
Antifungal Activity
50%
Antiinfective Agent
100%
Antimicrobial Agent
50%
Aspergillus Niger
50%
Azide
50%
Bacterial Infection
50%
Biological Marker
40%
Candida Albicans
50%
Carbene
50%
Chloramphenicol
50%
Clinical Trial
20%
Cytoprotective Agent
40%
Cytotoxicity
100%
Degenerative Disease
40%
Disease Exacerbation
20%
Drug Development
100%
Fluconazole
50%
Gram Negative Bacterium
50%
Indole
100%
Infectious Agent
100%
Inflammation
20%
Mycosis
50%
Nystatin
50%
Protein P53
40%
Pyrazole
50%
Pyrazolone
100%
Tolerability
50%
Triazole
100%
Keyphrases
1H-1,2,3-triazole
50%
Cellular Damage
50%
Cellular Stress
50%
Clinical Signs
50%
Clinical Trials
50%
Copper-catalyzed Azide-alkyne Cycloaddition (CuAAC)
50%
Degenerative Disease
100%
Disease Progression
50%
DNA Damage
50%
Drug Development
100%
Early Biomarker
100%
ESKAPE Pathogens
100%
Histological Analysis
50%
HMOX1
50%
In Vivo Reporter
50%
Inflammation
50%
Knoevenagel Condensation
50%
Neurodegenerative Diseases
50%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
100%
Oxidative Stress
50%
P53 Pathway
50%
Pyrazole-3-one
50%
Recent Advances
50%
Reporter Expression
100%
Reporter Mice
50%
Specific Mechanisms
50%
TAR DNA-binding Protein 43 (TDP-43)
100%
Therapeutic Intervention
50%
